pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keynote,671', 'nsclc', 'pembro', 'sclc', 'keynote-671']
#asco23 day 2
keynote-671: efs benefit with neoadjuvant pembro plus chemo followed by resection and adjuvant pembro in early-stage nsclc 
Hematology/Oncology
Empowered 
She/Her

Views are my own.